CompletedPhase 1NCT00195637
Intravenous Immune Globulin to Treat Hereditary Inclusion Body Myopathy
Studying Inclusion body myopathy with Paget disease of bone and frontotemporal dementia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Human Genome Research Institute (NHGRI)
- Principal Investigator
- William A Gahl, M.D.National Human Genome Research Institute (NHGRI)
- Intervention
- Immune Globulin(drug)
- Enrollment
- 4 enrolled
- Eligibility
- 18-70 years · All sexes
- Timeline
- 2005 – 2006
Study locations (1)
- National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00195637 on ClinicalTrials.gov